Aerie Pharmaceuticals, Inc. (AERI) stock prices updated...

Aerie Pharmaceuticals, Inc. stock price

Aerie Pharmaceuticals, Inc. latest news:

  • 08/02/2017 10:00:18

    Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2

    Aerie Pharmaceuticals Inc AERI posted second quarter 2017 loss of 82 cents per share including stock based compensation narrower than the Zacks Consensus Estimate of a loss of 84 cents and the year ago loss of 87 cents Being a development stage company Aerie has not generated

  • 08/01/2017 15:01:54

    BRIEF-Aerie Pharmaceuticals Q2 adj loss $0.63/shr

    * Aerie Pharmaceuticals reports second quarter 2017 financial results and provides business update

  • 07/19/2017 14:19:21

    BRIEF-Aerie Pharmaceuticals reports positive Roclatan phase 3 12-month topline safety results

    * Aerie Pharmaceuticals reports positive roclatan™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% phase 3 12-month topline safety results

  • More trends:

    AeroVironment, Inc.AVAV | AEterna Zentaris Inc.AEZS | Aethlon Medical, Inc.AEMD | Affimed N.V.AFMD | Affymetrix, Inc.AFFX | Agenus Inc.AGEN | Agile Therapeutics, Inc.AGRX | Agilysys, Inc.AGYS | Agios Pharmaceuticals, Inc.AGIO | AgroFresh Solutions, Inc.AGFS |